HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stephan Grabbe Selected Research
Stephan Grabbe Research Topics
Disease
52
Neoplasms (Cancer)
01/2024 - 12/2004
37
Melanoma (Melanoma, Malignant)
01/2023 - 01/2003
9
Inflammation (Inflammations)
03/2024 - 02/2002
9
Hypersensitivity (Allergy)
09/2020 - 01/2002
7
Infections
09/2022 - 01/2003
6
Hidradenitis Suppurativa
12/2023 - 01/2022
6
Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022 - 09/2006
5
Autoimmune Diseases (Autoimmune Disease)
01/2024 - 09/2006
5
Vitiligo
01/2023 - 01/2020
5
Neoplasm Metastasis (Metastasis)
01/2023 - 01/2017
5
Skin Neoplasms (Skin Cancer)
01/2023 - 05/2006
5
Acne Vulgaris
06/2022 - 10/2006
5
Atopic Dermatitis (Atopic Eczema)
01/2022 - 05/2006
4
Disease Progression
04/2022 - 12/2006
4
Skin Diseases (Skin Disease)
01/2022 - 12/2003
3
Brain Neoplasms (Brain Tumor)
01/2023 - 12/2018
3
Pain (Aches)
06/2022 - 03/2020
3
Alopecia (Baldness)
05/2022 - 01/2020
3
Contact Dermatitis (Eczema, Contact)
09/2020 - 10/2005
3
Allergic Contact Dermatitis
03/2010 - 01/2002
2
Sepsis (Septicemia)
03/2024 - 10/2012
2
Reinfection
01/2024 - 02/2020
2
Fibrosis (Cirrhosis)
01/2023 - 05/2022
2
Pyoderma Gangrenosum
10/2022 - 03/2014
2
Liver Cirrhosis (Hepatic Cirrhosis)
05/2022 - 01/2005
2
Cellulite
05/2022 - 04/2022
2
Psoriatic Arthritis
05/2022 - 01/2005
2
Communicable Diseases (Infectious Diseases)
03/2021 - 11/2016
2
Fatigue
01/2021 - 06/2009
2
Hypoxia (Hypoxemia)
12/2020 - 08/2013
2
Asthma (Bronchial Asthma)
11/2018 - 05/2006
2
Lichen Planus (Lichen Ruber Planus)
07/2017 - 07/2017
2
Carcinogenesis
05/2015 - 07/2007
2
Colitis
03/2014 - 04/2012
2
Hypertension (High Blood Pressure)
11/2013 - 09/2011
2
Virus Diseases (Viral Diseases)
01/2011 - 05/2006
2
Diarrhea
06/2009 - 09/2007
2
HIV Infections (HIV Infection)
09/2007 - 10/2004
Drug/Important Bio-Agent (IBA)
15
Immune Checkpoint Inhibitors
IBA
12/2023 - 07/2016
13
Antigens
IBA
10/2023 - 08/2003
9
Vaccines
IBA
01/2022 - 12/2004
7
Integrins
IBA
01/2024 - 01/2002
6
Cytokines
IBA
03/2024 - 05/2006
6
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2023 - 01/2021
6
Nanovaccines
IBA
01/2023 - 01/2013
6
Ipilimumab
IBA
01/2021 - 01/2013
5
cyclopropapyrroloindole
IBA
01/2023 - 01/2020
5
Neoplasm Antigens (Tumor Antigens)
IBA
10/2016 - 12/2004
4
Imiquimod (Aldara)
FDA Link
Generic
02/2023 - 05/2006
4
Haptens
IBA
12/2022 - 08/2003
4
pembrolizumab
IBA
01/2021 - 01/2017
4
RNA (Ribonucleic Acid)
IBA
01/2020 - 01/2016
4
Immunoglobulin E (IgE)
IBA
01/2019 - 09/2009
3
Peptides (Polypeptides)
IBA
10/2023 - 01/2016
3
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2023 - 01/2020
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2023 - 01/2011
3
Cancer Vaccines
IBA
01/2023 - 10/2016
3
Janus Kinase Inhibitors
IBA
01/2023 - 01/2020
3
Interleukin-10 (Interleukin 10)
IBA
01/2023 - 07/2007
3
Anti-Bacterial Agents (Antibiotics)
IBA
09/2022 - 01/2022
3
Proteins (Proteins, Gene)
FDA Link
05/2022 - 03/2010
3
Etanercept (Enbrel)
FDA Link
05/2022 - 01/2005
3
Retinoids
IBA
01/2022 - 06/2020
3
Vemurafenib
IBA
01/2021 - 01/2015
3
Interferons
IBA
01/2021 - 01/2011
3
Allergens
IBA
09/2020 - 02/2007
3
Interleukins
IBA
01/2020 - 01/2009
3
Glucose (Dextrose)
FDA Link
Generic
11/2016 - 09/2007
3
Angiotensin II
IBA
11/2013 - 09/2011
2
Nanogels
IBA
10/2023 - 01/2022
2
Anthralin (Dithranol)
IBA
01/2023 - 09/2022
2
Calcineurin Inhibitors
IBA
01/2023 - 01/2006
2
Interleukin-17 (Interleukin 17)
IBA
01/2023 - 06/2022
2
Interleukin-23 (Interleukin 23)
IBA
01/2023 - 01/2020
2
Mitogen-Activated Protein Kinases
IBA
01/2023 - 09/2021
2
Interleukin-18 (Interleukin 18)
IBA
01/2023 - 01/2009
2
Interleukin-12 (IL 12)
IBA
08/2022 - 01/2009
2
Indicators and Reagents (Reagents)
IBA
07/2022 - 02/2007
2
Monoclonal Antibodies
IBA
06/2022 - 09/2020
2
Androgens
IBA
06/2022 - 08/2020
2
Botulinum Toxins (Botulinum Toxin)
IBA
05/2022 - 03/2020
2
dupilumab
IBA
01/2022 - 09/2020
2
mRNA Vaccines
IBA
11/2021 - 01/2020
2
Antioxidants
IBA
10/2021 - 01/2020
2
cobimetinib
IBA
01/2021 - 06/2018
2
Nivolumab
IBA
01/2021 - 01/2017
2
Erbium
IBA
08/2020 - 04/2020
2
Phosphotransferases (Kinase)
IBA
01/2020 - 01/2016
2
Steroids
IBA
01/2020 - 01/2006
2
Biomarkers (Surrogate Marker)
IBA
01/2013 - 12/2006
2
Ligands
IBA
10/2005 - 02/2002
1
Chemokines
IBA
03/2024
Therapy/Procedure
46
Therapeutics
01/2024 - 10/2004
19
Immunotherapy
12/2023 - 12/2004
8
Radiotherapy
01/2023 - 12/2004
4
Lasers (Laser)
05/2022 - 04/2020
2
Ambulatory Care (Outpatient Care)
12/2023 - 01/2023
2
Phototherapy (Light Therapy)
01/2023 - 04/2020
2
Drug Therapy (Chemotherapy)
02/2022 - 01/2016
2
Dye Lasers
01/2022 - 04/2020